Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable TherapiesBusiness Wire • 04/16/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of InvestorsBusiness Wire • 04/12/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of InvestorsBusiness Wire • 04/12/24
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of MigrainePRNewsWire • 04/12/24
AbbVie (ABBV) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 04/11/24
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024InvestorPlace • 04/11/24
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of InvestorsBusiness Wire • 04/10/24
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next DecadeThe Motley Fool • 04/09/24